Try our beta test site
17 studies found for:    Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
Conditions: Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolus
Interventions: Drug: Twice daily enoxaparin prophylaxis;   Drug: Real time dose adjustment
2 Recruiting Thrombosis Outcomes in Pediatric Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
3 Recruiting Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Pulmonary Embolism;   Renal Artery Stenosis;   Pulmonary Cancer
Interventions: Drug: Low Volume iso-osmolar non-ionic radio contrast medium;   Drug: Acetylcysteine Inhalation;   Drug: Sodium Bicarbonate Solution;   Procedure: 64-MDCT Scanning
4 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
5 Not yet recruiting Apixaban in Preventing Secondary Cancer Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy
Conditions: Deep Vein Thrombosis;   Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Pulmonary Embolism
Intervention: Drug: Apixaban
6 Recruiting Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Conditions: Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions: Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
7 Recruiting A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions: Genetic: Genotype-guided;   Other: Standard-of-Care
8 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
9 Recruiting A Randomized Trial of Induction Versus Expectant Management
Condition: Labor and Delivery
Intervention: Procedure: Elective Induction of Labor
10 Recruiting Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Conditions: Thromboembolism of Vein VTE in Colorectal Cancer;   Thromboembolism of Vein in Pancreatic Cancer;   Thromboembolism of Vein in Non-small Cell Lung Cancer
Intervention: Drug: Isoquercetin
11 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
12 Recruiting Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
Conditions: Thromboembolism;   Blood Coagulation Disorders;   Cardiovascular Disease;   Vascular Disease
Intervention: Other: Patient Self-Monitoring vs Anticoagulation Clinic
13 Recruiting Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
Conditions: Thrombosis;   Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Primrose oil;   Dietary Supplement: Fish Oil
14 Recruiting Fatty Acid Regulation of Platelet Function in Diabetes
Conditions: Thrombosis;   Type 2 Diabetes Mellitus
Intervention: Other: omega-3 and -6 fatty acids and their 12-LOX oxylipins
15 Recruiting Physical Activity in Children at Risk of Post-thrombotic Syndrome (PACT)
Conditions: Post Thrombotic Syndrome;   Deep Vein Thrombosis
Interventions: Device: Fitbit;   Behavioral: 30-minute education session
16 Not yet recruiting Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Conditions: Deep Vein Thrombosis;   Post-Thrombotic Syndrome;   Venous Thrombosis
Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA);   Drug: Standard Anticoagulation Therapy
17 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Adenovirus;   Adrenal Insufficiency;   Airway Swelling;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Brain Swelling;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Edema;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Headaches;   Herpes Simplex Virus;   Hypertension;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Influenza;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Prophylaxis;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Stable Angina;   Thromboprophylaxis;   Thrombosis;   Treatment-resistant Schizophrenia;   Urinary Tract Infection;   Withdrawal
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

Study has passed its completion date and status has not been verified in more than two years.